SBI-002

N/A

Report date: 2024/09/29 14:52:19

Base Information

Drug NameSBI-002
Drug Alias NameSBI002
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpecific Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpecific Biologics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A